Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon

December 16, 2024

Unlock the Editor’s Digest without costRoula Khalaf, Editor of the FT, selects her favorite tales on this weekly publication.Goldman Sachs Asset Administration has agreed a greater than €2bn deal to ...

8 Best Investments for Retirement

ATFX Meets Prince Edward, Duke of Edinburgh, at Windsor Castle During London Experience

S&P 500 Technical Analysis: Key risks ahead include the US CPI and the APEC Summit

Aifinyo AG Becomes Germany’s First Bitcoin Treasury Firm with $3.5M Pure-play Investment

How to prepare your portfolio for lower interest rates: top advisors

Beyond Meat soars on meme ETF add, Walmart deal

Bitcoin Is Mirroring Soybean Chart Before 1970s Crash: Peter Brandt

OpenAI’s Atlas Browser Takes Direct Aim at Google Chrome

7 Types of Financial Advisors & When to Hire Them

EUR/USD strives to gain ground near 1.1600, outlook remains uncertain

What to Know About the ICE Raid at a Hyundai Plant

Team Behind Layer 1 Cadena Discontinues Support

Tag: Synthon

Goldman Sachs’ investment arm agrees €2bn deal for drugmaker Synthon

Private equity groups prepare to offload Ensemble Health for up to $12bn

The human harbor: Navigating identity and meaning in the AI age

Equinor scales back renewables push 7 years after ditching ‘oil’ from its name

Niels Troost has a staggering story to tell about how he got sanctioned

Why America’s economy is soaring ahead of its rivals

Dollar climbs after Donald Trump’s Brics tariff threat and French political woes

Nato chief Mark Rutte’s warning to Trump

Top Federal Reserve official warns progress on taming US inflation ‘may be stalling’

8 Best Investments for Retirement

ATFX Meets Prince Edward, Duke of Edinburgh, at Windsor Castle During London Experience

S&P 500 Technical Analysis: Key risks ahead include the US CPI and the APEC Summit

Aifinyo AG Becomes Germany’s First Bitcoin Treasury Firm with $3.5M Pure-play Investment

Live Prices